Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry
Access Your Copy of the Manuscript
This published study was conducted by Theodore Leng, MD, MS, and a team of researchers from Verana Health.
Analyzes the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight) data for insights into characterizing AMD
Uses curated real-world data from the Academy’s IRIS Registry to better understand how patients progress through the stages of dry AMD (dAMD)
Reports on how AMD, as determined by visual acuity, can help predict the risk of progression in dry AMD by stage.
Complete the form to access your copy.
Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.